To the top

Page Manager: Webmaster
Last update: 9/11/2012 3:13 PM

Tell a friend about this page
Print version

The myxoid liposarcoma FU… - University of Gothenburg, Sweden Till startsida
To content Read more about how we use cookies on

The myxoid liposarcoma FUS-DDIT3 fusion oncoprotein deregulates NF-kappaB target genes by interaction with NFKBIZ.

Journal article
Authors Melker Göransson
Mattias K Andersson
C Forni
Anders Ståhlberg
Carola Andersson
A. Olofsson
R Mantovani
Pierre Åman
Published in Oncogene
Volume 28
Issue 2
Pages 270-8
ISSN 1476-5594
Publication year 2009
Published at Institute of Neuroscience and Physiology, Department of Clinical Neuroscience and Rehabilitation
Institute of Biomedicine, Department of Pathology
Pages 270-8
Language en
Keywords Acute-Phase Proteins, biosynthesis, genetics, Binding Sites, CCAAT-Enhancer-Binding Proteins, physiology, Cell Line, Tumor, metabolism, Cell Nucleus, metabolism, ultrastructure, Fibrosarcoma, metabolism, pathology, Humans, Interleukin-6, biosynthesis, genetics, Interleukin-8, biosynthesis, genetics, Lipocalins, biosynthesis, genetics, Liposarcoma, Myxoid, genetics, pathology, NF-kappa B, physiology, Neoplasm Proteins, genetics, physiology, Nuclear Proteins, physiology, Oncogene Proteins, Fusion, genetics, physiology, Promoter Regions, Genetic, genetics, Protein Binding, Protein Interaction Mapping, Proto-Oncogene Proteins, biosynthesis, genetics, RNA-Binding Protein FUS, genetics, physiology, Transcription Factor CHOP, genetics, physiology, Transcription, Genetic
Subject categories Medical and Health Sciences


FUS (also called TLS), EWSR1 and TAF15 (also called TAF2N) are related genes involved in tumor type-specific fusion oncogenes in human malignancies. The FUS-DDIT3 fusion oncogene results from a t(12;16)(q13;p11) chromosome translocation and has a causative role in the initiation of myxoid/round cell liposarcomas (MLS/RCLS). The FUS-DDIT3 protein induces increased expression of the CAAT/enhancer-binding protein (C/EBP) and nuclear factor-kappaB (NF-kappaB)-controlled gene IL8, and the N-terminal FUS part is required for this activation. Chromatin immunoprecipitation analysis showed that FUS-DDIT3 binds the IL8 promoter. Expression studies of the IL8 promoter harboring a C/EBP-NF-kappaB composite site pinpointed the importance of NF-kappaB for IL8 expression in FUS-DDIT3-expressing cells. We therefore probed for possible interaction of FUS-DDIT3 with members of the NF-kappaB family. The nuclear factor NFKBIZ colocalizes with FUS-DDIT3 in nuclear structures, and immunoprecipitation experiments showed that FUS-DDIT3 binds the C-terminal of NFKBIZ. We also report that additional NF-kappaB-controlled genes are upregulated at the mRNA level in FUS-DDIT3-expressing cell lines and they can be induced by NFKBIZ. Taken together, the results indicate that FUS-DDIT3 deregulates some NF-kappaB-controlled genes through interactions with NFKBIZ. Similar mechanisms may be a part of the transformation process in other tumor types carrying FUS, EWSR1 and TAF15 containing fusion oncogenes.

Page Manager: Webmaster|Last update: 9/11/2012

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?